Impact evaluation of Australian national HPV vaccination program

Submitted by Anonymous on

NCIRS evaluation of the impact of the national HPV vaccination program has found that HPV vaccination coverage is high and there has been a substantial reduction in the burden of HPV-related disease since the introduction of the vaccine in Australia. It was also found that adverse events following immunisation with HPV vaccine have been predominantly mild and transient in nature, with the vaccine safety record similar to that of other vaccines on the National Immunisation Program.

COVID-19: Impact on routine childhood vaccination uptake in Australia

Submitted by Anonymous on

This report shows analysis of the impact of COVID-19 pandemic and associated response measures on routine childhood immunisation using Australian Immunisation Register data. There was no evidence of substantial impact on vaccination uptake in children at national or state/territory level, for vaccinations due up to July 2020, which is a reflection of consistent messaging from health authorities about maintaining routine immunisations during the pandemic and providing COVID-19 safe vaccination opportunities. 

Key findings - Annual Immunisation Coverage Report 2019

Submitted by Anonymous on

This summary report presents key findings from the Annual Immunisation Coverage Report 2019 which focussed on changes in immunisation coverage among all children aged <5 years at key milestone ages of 12, 24 and 60 months between 2018 and 2019. The summary report shows 'fully vaccinated' coverage at 12, 24 and 60 months; individual vaccine/antigen coverage; MMR and influenza vaccination coverage; and vaccination coverage among Aboriginal and Torres Strait Islander children.

Annual Immunisation Coverage Report 2019

Submitted by Anonymous on

The Annual Immunisation Coverage Report 2019 is the 13th in the series, and shows data for the calendar year 2019 derived from the Australian Immunisation Register for all children aged <5 years. The report focusses on changes in vaccination coverage at key milestone ages of 12, 24 and 60 months between 2018 and 2019, but also documents important trends and their relationship to relevant policy and program changes. ‘Fully vaccinated’ coverage increased at all three age milestones in all children.

Subscribe to Immunisation coverage